Source: Dia a Diaes

Residents of Itapemirim who tested positive for coronavirus will receive free, starting this Wednesday (1) the HCQ, which is composed of the drugs ivermectin, zinc, azithromycin and hydroxychloroquine.

According to the City Hall of Itapemirim, the delivery of medicines will be made exclusively to the two Sentinel units in the municipality, specific for patients with symptoms of coronavirus, located in Vila and Itaipava.

Before receiving the kit, the patient undergoes an examination to prove the disease. For this, the city announced the purchase, through bidding, of the rapid tests that will allow testing between 2 to 3 thousand people.

With regard to the kit, the city recalls that the patient has the choice of whether or not to use the drugs and that, if he wishes to receive them, he will sign a term of responsibility and authorization.

Purchase delay

The initial forecast, according to Mayor Thiago Peçanha, was that the drugs were already available until the 23rd of last month, however, there was a delay in the purchase of the products.

The city stressed, by means of a note, that it opted to bid on medicines, as it was safer, more cohesive and transparent. However, he explained, at the opening of the dispute, which occurred on the 25th, he managed to acquire two of the four drugs that make up the kit.

“Due to the need for acquisition, after bidding, we decided to purchase the other two drugs through dispensation. We even got a price quote in the lower amount than we expected in the bidding process ”, said the city hall, in a note.

Related:

Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows

C19 Study: 48 studies (28 peer reviewed) showing “very positive” results using HCQ as pre & post exposure prophylaxis & early treatment.

Covid-19: Portugal without cases of “adverse reactions” to hydroxychloroquine

HIBISCUS: Hydroxychloroquine for the Secondary Prevention of Thrombotic and Obstetrical Events in Primary Antiphospholipid Syndrome

Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection.

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »